Literature DB >> 22246480

Appropriate cut-off values of waist circumference to predict cardiovascular outcomes: 7-year follow-up in an Iranian population.

Mohammad Talaei1, G Neil Thomas, Tom Marshall, Masoumeh Sadeghi, Rokhsareh Iranipour, Shahram Oveisgharan, Nizal Sarrafzadegan.   

Abstract

OBJECTIVE: Due to the lack of compelling evidence for waist circumference (WC) as a cardiovascular disease (CVD) risk factor in many ethnic groups, the need for local research has been expressed by international authorities. This study was undertaken to determine the optimal cut-off points of WC for predicting incident CVD and metabolic syndrome in an Iranian population.
MATERIALS AND METHODS: A total of 6,504 participants from three areas in central Iran were followed over 7 years. Receiver operating characteristics (ROC) and area under the curve (AUC) were used to identify the maximum value of sensitivity and specificity combinations corresponding to the appropriate cut-off points of WC for the detection of the metabolic syndrome and CVD events. The optimal cut-off values were defined as the point at which the value of "sensitivity+specificity-1" reached the maximum value. Finally, Cox proportional hazard modeling was used to determine which cut-off point was better fit in the CVD risk prediction model.
RESULTS: After 394,418 person-years of follow-up, 427 incident primary CVD events (233 men) were identified. Considering CVD, the optimum cut-off points were 99/103.5 cm (men/women) but these had a low sensitivity (AUC: 0.59, 95%CI 0.55-0.63 in both men and women). The second highest values for discriminating CVD were 93/97 cm that resulted in acceptable sensitivity. Regarding the metabolic syndrome, 92.6/97.8 cm were identified as optimum (AUC: 0.67, 95%CI 0.65-0.69 in men and 0.65, 95%CI 0.63-0.67 in women). The best cut-off values that fit in the Cox regression model were 90/97 cm.
CONCLUSION: International recommended WC cut-off values for the Middle East are not appropriate compared to the locally defined cut-off values in Iran.

Entities:  

Mesh:

Year:  2012        PMID: 22246480     DOI: 10.2169/internalmedicine.51.6132

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  9 in total

1.  PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region.

Authors:  Nizal Sarrafzadegan; Razieh Hassannejad; Hamid Reza Marateb; Mohammad Talaei; Masoumeh Sadeghi; Hamid Reza Roohafza; Farzad Masoudkabir; Shahram Oveisgharan; Marjan Mansourian; Mohammad Reza Mohebian; Miquel Angel Mañanas
Journal:  PLoS One       Date:  2017-12-19       Impact factor: 3.240

2.  Comparison of components of metabolic syndrome in premature myocardial infarction in an Iranian population: a case -control study.

Authors:  Toba Kazemi; Gholamreza Sharifzadeh; Asghar Zarban; Azita Fesharakinia
Journal:  Int J Prev Med       Date:  2013-01

3.  The cut-off values of anthropometric indices for identifying subjects at risk for metabolic syndrome in Iranian elderly men.

Authors:  Mojgan Gharipour; Masoumeh Sadeghi; Minoo Dianatkhah; Shirin Bidmeshgi; Alireza Ahmadi; Marzieh Tahri; Nizal Sarrafzadegan
Journal:  J Obes       Date:  2014-03-23

Review 4.  Prevalence of Metabolic Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-Analysis.

Authors:  Bahareh Amirkalali; Hossein Fakhrzadeh; Farshad Sharifi; Roya Kelishadi; Farhad Zamani; Hamid Asayesh; Saeid Safiri; Tahereh Samavat; Mostafa Qorbani
Journal:  Iran Red Crescent Med J       Date:  2015-12-27       Impact factor: 0.611

5.  Prevalence of metabolic syndrome in Iran: A meta-analysis.

Authors:  Rahim Ostovar; Faezeh Kiani; Fatemeh Sayehmiri; Masood Yasemi; Yazdan Mohsenzadeh; Yousof Mohsenzadeh
Journal:  Electron Physician       Date:  2017-10-25

6.  The cumulative incidence of conventional risk factors of cardiovascular disease and their population attributable risk in an Iranian population: The Isfahan Cohort Study.

Authors:  Masoumeh Sadeghi; Mohammad Talaei; Shahram Oveisgharan; Katayoun Rabiei; Minoo Dianatkhah; Ahmad Bahonar; Nizal Sarrafzadegan
Journal:  Adv Biomed Res       Date:  2014-11-29

7.  Prevalence and determinants of metabolic syndrome in Qatar: results from a National Health Survey.

Authors:  Mohamed Hamad Al-Thani; Al Anoud Mohammed Al-Thani; Sohaila Cheema; Javaid Sheikh; Ravinder Mamtani; Albert B Lowenfels; Walaa Fattah Al-Chetachi; Badria Ali Almalki; Shamseldin Ali Hassan Khalifa; Ahmad Omar Haj Bakri; Patrick Maisonneuve
Journal:  BMJ Open       Date:  2016-09-06       Impact factor: 2.692

8.  Cardiovascular disease events and its predictors in women: Isfahan Cohort Study (ICS).

Authors:  Masoumeh Sadeghi; Azam Soleimani; Hamidreza Roohafza; Safoura Yazdekhasti; Shahram Oveisgharan; Mohammad Talaei; Nizal Sarrafzadegan
Journal:  J Cardiovasc Thorac Res       Date:  2017-08-21

9.  Discriminatory Capacity of Anthropometric Indices for Cardiovascular Disease in Adults: A Systematic Review and Meta-Analysis.

Authors:  Mitra Darbandi; Yahya Pasdar; Shima Moradi; Hamid Jan Jan Mohamed; Behrooz Hamzeh; Yahya Salimi
Journal:  Prev Chronic Dis       Date:  2020-10-22       Impact factor: 2.830

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.